HURWITZ EDWARD Insider Trades

Insider Trading History

Track insider trading activity for HURWITZ EDWARD. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Dyne Therapeutics
Dyne Therapeutics DYN
Director
Holding Value $712k 35,152 shares
Last Trade
Jun 05, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$599k 35,152 shares
$17.04
$20.26
Macrogenics
Macrogenics MGNX
Director
Holding Value $103k 22,000 shares
Last Trade
May 19, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$99.4k 22,000 shares
$4.52
$4.69
Macrogenics
Macrogenics MGNX
Director
Holding Value $17.6k 3,750 shares
Last Trade
May 19, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$17k 3,750 shares
$4.52
$4.69
Macrogenics
Macrogenics MGNX
Director
Holding Value $0 0 shares
Last Trade
May 18, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$16.3k 3,750 shares
$4.35
$4.69
Macrogenics
Macrogenics MGNX
Director
Holding Value $224k 47,824 shares
Last Trade
May 18, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$16.3k 3,750 shares
$4.35
$4.69
Dyne Therapeutics
Dyne Therapeutics DYN
Director
Holding Value $709k 35,000 shares
Last Trade
May 30, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$419k 35,000 shares
$11.96
$20.26
Macrogenics
Macrogenics MGNX
Director
Holding Value $103k 22,000 shares
Last Trade
May 21, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$32.8k 22,000 shares
$1.49
$4.69
Macrogenics
Macrogenics MGNX
Director
Holding Value $207k 44,074 shares
Last Trade
May 20, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$10.2k 6,500 shares
$1.57
$4.69
Macrogenics
Macrogenics MGNX
Director
Holding Value $0 0 shares
Last Trade
May 20, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$10.2k 6,500 shares
$1.57
$4.69
Dyne Therapeutics
Dyne Therapeutics DYN
Director
Holding Value $509k 25,133 shares
Last Trade
May 22, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$792k 25,133 shares
$31.53
$20.26
Macrogenics
Macrogenics MGNX
Director
Holding Value $30.5k 6,500 shares
Last Trade
May 21, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$27.7k 6,500 shares
$4.26
$4.69
Macrogenics
Macrogenics MGNX
Director
Holding Value $77.4k 16,500 shares
Last Trade
May 21, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$70.3k 16,500 shares
$4.26
$4.69
Macrogenics
Macrogenics MGNX
Director
Holding Value $176k 37,574 shares
Last Trade
May 20, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$19.2k 4,500 shares
$4.26
$4.69
Macrogenics
Macrogenics MGNX
Director
Holding Value $0 0 shares
Last Trade
May 20, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$19.2k 4,500 shares
$4.26
$4.69
Macrogenics
Macrogenics MGNX
Director
Holding Value $155k 33,074 shares
Last Trade
Aug 30, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$73.7k 15,000 shares
$4.91
$4.69
Macrogenics
Macrogenics MGNX
Director
Holding Value $89.1k 19,000 shares
Last Trade
May 31, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$88.7k 19,000 shares
$4.67
$4.69
Dyne Therapeutics
Dyne Therapeutics DYN
Director
Holding Value $504k 24,900 shares
Last Trade
May 24, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$336k 24,900 shares
$13.49
$20.26
Applied Genetic Technologies
Applied Genetic Technologies AGTC
Director
Holding Value $0 0 shares
Last Trade
Nov 30, 2022 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$5.51k 14,000 shares
$0.39
$0.39
Applied Genetic Technologies
Applied Genetic Technologies AGTC
Director
Holding Value $0 0 shares
Last Trade
Nov 30, 2022 Sale (Tender)Reported as Tender on SEC Form 4.
$708 1,800 shares
$0.39
$0.39
Dyne Therapeutics
Dyne Therapeutics DYN
Director
Holding Value $397k 19,596 shares
Last Trade
Jun 03, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$89.7k 19,596 shares
$4.58
$20.26

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up